Since the data on PUFA metabolism and FADS polymorphisms remain inconclusive, this review aimed to examine the influence of FADS1 and FADS2 gene variants on metabolism and biological effects of omega-3 fatty acids and gamma-linolenic acid, both individually and in combination, in cancer patients. This evidence concerns the gene FADS2 and cancer.